MDSKX
Price
$31.63
Change
-$0.16 (-0.50%)
Updated
Jul 31 closing price
Net Assets
3.98B
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

MDSKX vs VSCIX

MDSKX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
MDSKX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDSKX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. MDSKX (3.98B). VSCIX pays higher dividends than MDSKX: VSCIX (1.23) vs MDSKX (0.79). MDSKX was incepted earlier than VSCIX: MDSKX (29 years) vs VSCIX (29 years). MDSKX (0.41) is less costly to investors than VSCIX (0.03). MDSKX is a more actively managed with annual turnover of: 21.00 vs. VSCIX (17.00). MDSKX has a lower initial minimum investment than VSCIX: MDSKX (1000) vs VSCIX (5000000). MDSKX annual gain was more profitable for investors over the last year : 31.08 vs. VSCIX (22.58). VSCIX return over 5 years is better than : 35.13 vs. MDSKX (22.71).
MDSKXVSCIXMDSKX / VSCIX
Total Expense Ratio0.370.031,233%
Annual Report Gross Expense Ratio0.410.031,367%
Fund Existence29 years29 years-
Gain YTD18.39014.591126%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.98B189B2%
Annual Yield % from dividends0.791.2364%
Returns for 1 year31.0822.58138%
Returns for 3 years42.7143.4498%
Returns for 5 years22.7135.1365%
Returns for 10 years114.37156.0773%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C